Professor Erica Sloan leads the Cancer Neural Immune Laboratory at Monash University, Australia. Her research program investigates how the sympathetic nervous system impacts cancer progression. Using advanced imaging technologies in preclinical models of cancer, she defined how chronic stress acts through neural signalling to control the behaviour of cancer cells, immune cells, and vasculature, to accelerate cancer metastasis. Her team recently completed a Phase II randomised controlled trial that found that blocking neural signalling in breast cancer patients reduced biomarkers of metastasis. Her team are currently applying this knowledge to improve standard cancer treatments.
Wednesday, 18 June 2025
Time |
Session |
|
09:20
10:55
|
-
The neural regulation of small cell lung cancer progression
-
Proffered Paper: Selected from Abstracts - to be announced in 2025
-
Neural mechanisms of brain tumor growth and resistance
-
Proffered Paper: Selected from Abstracts - to be announced in 2025
-
Neural-tumour communication accelerates cancer progression and impairs treatment response
Auditorium 2
|